Discontinued — last reported Q4 '25
Contract-Manufactured Products — Net Sales
West Pharmaceutical Services Contract-Manufactured Products — Net Sales decreased by 8.8% to $143.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $134.90M to $143.20M. Over 2 years (FY 2023 to FY 2025), Contract-Manufactured Products — Net Sales shows relatively stable performance with a 2.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher sales indicate strong demand for the segment's manufacturing capacity and successful client acquisition.
Detailed definition
The total revenue generated from providing contract manufacturing services to third-party pharmaceutical and biotechnolo...
Peer comparison
Comparable to 'Contract Manufacturing Revenue' or 'Service Revenue' in peer pharmaceutical supply chain companies.
wst_segment_contract_manufactured_products_net_salesHistorical Data
| Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.70M | $133.50M | $135.80M | $144.90M | $138.30M | $135.90M | $142.40M | $145.50M | $134.90M | $135.00M | $146.70M | $157.10M | $143.20M |
| QoQ Change | — | +12.5% | +1.7% | +6.7% | -4.6% | -1.7% | +4.8% | +2.2% | -7.3% | +0.1% | +8.7% | +7.1% | -8.8% |
| YoY Change | — | +12.5% | — | — | — | +1.8% | +4.9% | +0.4% | -2.5% | -0.7% | +3.0% | +8.0% | +6.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's contract-manufactured products — net sales?
- West Pharmaceutical Services (WST) reported contract-manufactured products — net sales of $143.20M in Q4 2025.
- How has West Pharmaceutical Services's contract-manufactured products — net sales changed year-over-year?
- West Pharmaceutical Services's contract-manufactured products — net sales increased by 6.2% year-over-year, from $134.90M to $143.20M.
- What is the long-term trend for West Pharmaceutical Services's contract-manufactured products — net sales?
- Over 2 years (2023 to 2025), West Pharmaceutical Services's contract-manufactured products — net sales has grown at a 2.6% compound annual growth rate (CAGR), from $552.50M to $582.00M.
- What does contract-manufactured products — net sales mean?
- Total revenue earned from contract manufacturing services after accounting for returns and discounts.